Time to redefine the role of routine combined-modality therapy for invasive stage-II/III rectal cancer?

Lily L. Lai, Charles Thomas

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)87-88
Number of pages2
JournalGastrointestinal Cancer Research
Volume3
Issue number2
StatePublished - 2009

Fingerprint

Combined Modality Therapy
Rectal Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Time to redefine the role of routine combined-modality therapy for invasive stage-II/III rectal cancer? / Lai, Lily L.; Thomas, Charles.

In: Gastrointestinal Cancer Research, Vol. 3, No. 2, 2009, p. 87-88.

Research output: Contribution to journalArticle

@article{33f36d3e80094835b9f1fd5037386400,
title = "Time to redefine the role of routine combined-modality therapy for invasive stage-II/III rectal cancer?",
author = "Lai, {Lily L.} and Charles Thomas",
year = "2009",
language = "English (US)",
volume = "3",
pages = "87--88",
journal = "Gastrointestinal Cancer Research",
issn = "1934-7820",
publisher = "International Society of Gastrointestinal Oncology",
number = "2",

}

TY - JOUR

T1 - Time to redefine the role of routine combined-modality therapy for invasive stage-II/III rectal cancer?

AU - Lai, Lily L.

AU - Thomas, Charles

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=77953436452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953436452&partnerID=8YFLogxK

M3 - Article

C2 - 19461914

AN - SCOPUS:77953436452

VL - 3

SP - 87

EP - 88

JO - Gastrointestinal Cancer Research

JF - Gastrointestinal Cancer Research

SN - 1934-7820

IS - 2

ER -